Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)

Market Cap	11.83B +16.9%
Revenue (ttm)	16.62B -4.7%
Net Income	1.28B +48.0%
EPS	0.77 +48.0%
Shares Out	1.66B
PE Ratio	9.23
Forward PE	9.37
Dividend	0.38 (5.34%)
Ex-Dividend Date	Jun 23, 2025

Volume	24,281,100
Average Volume	30,752,813
Open	7.21
Previous Close	7.24
Day's Range	7.11 - 7.23
52-Week Range	5.91 - 8.55
Beta	0.33
RSI	44.84
Earnings Date	Mar 17, 2026

About SHA:600866

Star Lake Bioscience Co., Inc.Zhaoqing Guangdong engages in the manufacture and sale of pharmaceutical raw materials, and food and feed additives under the Star Lake and Yue Bao brand names in China and internationally. The company offers L-proline for use as an intermediate for synthesizing captopril and enalapril, and raw material for amino acid transfusion; guanosine that is used as an intermediate for food and pharmaceutical raw material; adefovir dipivoxil tablets used to reduce the activity of HBV DNA polymerase and anti-virus by destroyi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1964
• Employees: 9,293
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600866

Financial Performance

In 2024, SHA:600866's revenue was 17.33 billion, a decrease of -0.23% compared to the previous year's 17.37 billion. Earnings were 943.15 million, an increase of 39.12%.